Angelique Collamer, MD, FACP, FACR

Angelique N. Collamer, MD, FACP, FACR, Lieutenant Colonel, Air Force

Name: Angelique N. Collamer, MD, FACP, FACR, Lieutenant Colonel, Air Force

USU Department of Primary Appointment: 
Medicine
Title: 
Service Chief, Rheumatology
Faculty Rank: 
Associate Professor
Location: 
Walter Reed National Military Medical Center, Bethesda, MD

Research Interests:
Anti-tumor necrosis factor alpha antagonists (focus on psoriasiform and other paradoxical reactions)
Military Medicine with a focus on practice and quality improvement

Office Phone: 
(301) 295-4512

Education

1996-2000, B.A. (Biological Sciences), Wellesley College, Wellesley, MA
2000-04, M.D., Uniformed Services University of the Health Sciences, Bethesda, MD
2004-07, Internal Medicine Internship and Residency, Wright Patterson AFB, Dayton, OH
2008-09, USSONAR Musculoskeletal Ultrasound Training and Testing Program Certificate
2007-09, Rheumatology Fellowship, San Antonio Uniformed Services Health Education Consortium (SAUSHEC), San Antonio, TX

Biography

Lt Col Angelique Collamer received her military commission through the ROTC program, Detachment #365, at the Massachusetts Institute of Technology. She completed medical school at the Uniformed Services University of the Health Sciences in Bethesda, MD. Dr. Collamer completed an Internal Medicine Internship and Residency at Wright Patterson Air Force Base in Dayton, OH and Rheumatology Fellowship at Brooke Army Medical Center. Upon fellowship graduation, she was selected as an American College of Rheumatology (ACR) Distinguished Fellow in 2009. While at Brooke Army Medical Center, she authored two landmark papers on the topic of tumor necrosis factor (TNF) antagonist induced psoriasis and served as the Director of Research for the Rheumatology Department. Dr. Collamer was subsequently assigned to U.S. Air Force Hospital Langley in Virginia. During this tour served as Medical Director of the Internal Medicine and Medical Subspecialty Clinics as well as the Commander for 8 clinical areas and a 110 member staff. Additionally, she was the Air Force member to the VA/DoD Non-Surgical Management of Hip & Knee Osteoarthritis Clinical Practice Guideline Working Group. Dr. Collamer was next assigned as the Air Force Company Commander and Assistant Commandant at the Uniformed Services University and also served as a staff rheumatologist at Walter Reed National Military Medical Center (WRNMMC). In 2017 she was selected as the Rheumatology Clinic Service Chief at WRNMMC where she can be found happily busy in patient care, clinical research and the teaching and mentoring of medical students, residents and fellows.

Representative publications, projects, and/or deployments

  • 2017, USU School of Medicine “Impact Award” for Academic Year 2016-2017
  • 2017, Vice-Governor, Air Force American College of Physicians (ACP) Chapter
  • 2013, Awarded Air Force “MF” Special Experience Identifier (SEI) for Excellence in Clinical/Academic Teaching
  • 2013-2017, Company Commander/Assistant Commandant, Uniformed Services University
  • 2013, USU James J. Leonard Award for Excellence in Teaching Internal Medicine, Academic Year 2011-2012
  • 2012, American College of Physicians (ACP), Air Force Chapter, Archie Hoffman Award, Field Category.
  • 2012-13, Flight Commander, Medical Specialties Clinics, USAF Hospital Langley
  • 2011-13, Medical Director (Chief), Medical Specialties Clinics, USAF Hospital Langley
  • 2009-10, Research Director, Brooke Army Medical Center, Rheumatology Clinic

Bibliography

  • Wagler V, Shippey A, Collamer A. Hydroxychloroquine: Old Medication with Current Relevance. Cleveland Clinic Journal of Medicine, 2018 Jun;85(6):459-467.
  • Eickhoff J, Collamer A. Autoimmunity Mimics: Infection and Malignancy. In: Primary Care Clinics in Office Practice on Rheumatology. Elsevier. 2018.
  • Hill EM, Sky K, Sit M, Collamer A, Higgs J. Does Starting Allopurinol Prolong Acute Treated Gout? A Randomized Clinical Trial. J Clin Rheum 2015;21:120-125.
  • VA/DoD Clinical Practice Guideline for the Non-Surgical Management of Hip & Knee Osteoarthritis. 2014. Available at: http://www.healthquality.va.gov/guidelines/CD/OA/.
  • Sky K, Arroyo R, Collamer A. Salmonella Septic Arthritis in a Patient Receiving Etanercept: Case Report and Review of the Literature. Military Medicine, 2013;178(12):e1384-87.
  • Collamer A, Battafarano D. A Pain in the Neck: Carotid Artery Dissection Presenting as Vasculitis. Military Medicine 2013;178(7):e851-4.
  • Collamer A, Battafarano D. Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: Clinical Features and Possible Immunopathogenesis. Semin Arthritis Rheum 2010;40:233-40.
  • Collamer A, Battafarano D. Expert Commentary: Tumor Necrosis Factor Antagonist Induced Psoriatic Skin Lesions. In: Tumor Necrosis Factor, Rossard TP ed. Nova Science Publishers, Inc., New York, 2009.
  • Collamer A, Battafarano D. The Treatment of Ankylosing Spondylitis and Psoriatic Arthritis with Etanercept: A Comprehensive Review. Clinical Medicine: Therapeutics 2009;1:27-43.
  • Collamer A, Guerrero K, Henning J, Battafarano D. Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: A Literature Review and Potential Mechanisms of Action. Arthritis Rheum 2008;59:905-1001.